CD226 and asthma: Notably, administering CD226-Fc in vivo produced a slightly higher therapeutic effect with Cd226fl/flCd4-Cre mice among OVA-induced mice with asthma, as evidenced by a lower percentage of eosinophils in BALF and lower levels of OVA-specific IgE and IgG1 in serum.